V
ViroGates A/S
CSE:VIRO
ViroGates A/S
CSE:VIRO
Price:
12.3
DKK
Market Cap:
kr114.1m
Balance Sheet
Balance Sheet Decomposition
ViroGates A/S
ViroGates A/S
Balance Sheet Decomposition is not available for
ViroGates A/S
ViroGates A/S
Balance Sheet
ViroGates A/S
ViroGates A/S
Currency: DKK
| Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||
| Cash & Cash Equivalents |
15
|
8
|
1
|
60
|
41
|
34
|
15
|
10
|
16
|
12
|
|
| Cash Equivalents |
15
|
8
|
1
|
60
|
41
|
34
|
15
|
10
|
16
|
12
|
|
| Total Receivables |
2
|
3
|
2
|
2
|
2
|
3
|
3
|
4
|
3
|
2
|
|
| Accounts Receivables |
1
|
2
|
0
|
0
|
0
|
2
|
1
|
2
|
2
|
1
|
|
| Other Receivables |
1
|
2
|
2
|
2
|
2
|
2
|
2
|
2
|
1
|
1
|
|
| Inventory |
0
|
0
|
1
|
1
|
0
|
1
|
2
|
4
|
5
|
3
|
|
| Other Current Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Current Assets |
17
|
12
|
5
|
63
|
44
|
38
|
20
|
17
|
24
|
17
|
|
| PP&E Net |
0
|
0
|
0
|
0
|
1
|
0
|
0
|
0
|
0
|
0
|
|
| Note Receivable |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Long-Term Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Assets |
17
N/A
|
12
-31%
|
5
-59%
|
63
+1 174%
|
45
-29%
|
38
-15%
|
20
-47%
|
18
-13%
|
25
+40%
|
18
-28%
|
|
| Liabilities | |||||||||||
| Accounts Payable |
1
|
1
|
0
|
0
|
1
|
4
|
0
|
1
|
2
|
0
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
|
| Other Current Liabilities |
2
|
2
|
2
|
2
|
2
|
3
|
3
|
1
|
1
|
1
|
|
| Total Current Liabilities |
3
|
3
|
2
|
2
|
3
|
7
|
4
|
1
|
2
|
3
|
|
| Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
5
|
4
|
|
| Other Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Liabilities |
3
N/A
|
3
0%
|
2
-34%
|
2
+22%
|
3
+22%
|
7
+136%
|
4
-45%
|
1
-62%
|
8
+420%
|
7
-9%
|
|
| Equity | |||||||||||
| Common Stock |
2
|
2
|
2
|
3
|
3
|
3
|
3
|
3
|
0
|
8
|
|
| Retained Earnings |
12
|
7
|
1
|
58
|
39
|
28
|
13
|
13
|
0
|
3
|
|
| Other Equity |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
17
|
0
|
|
| Total Equity |
14
N/A
|
9
-38%
|
3
-67%
|
61
+1 936%
|
42
-31%
|
31
-26%
|
16
-48%
|
16
-2%
|
17
+6%
|
11
-37%
|
|
| Total Liabilities & Equity |
17
N/A
|
12
-31%
|
5
-59%
|
63
+1 174%
|
45
-29%
|
38
-15%
|
20
-47%
|
18
-13%
|
25
+40%
|
18
-28%
|
|
| Shares Outstanding | |||||||||||
| Common Shares Outstanding |
2
|
2
|
2
|
3
|
3
|
4
|
4
|
4
|
6
|
8
|
|
Switch to:
Switch to:
See Also
Discover More
